Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pfizer (NY: PFE )

28.07 -0.11 (-0.37%)
Streaming Delayed Price Updated: 9:58 AM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,724,255
Open 28.24
Bid (Size) 28.07 (35)
Ask (Size) 28.08 (17)
Prev. Close 28.18
Today's Range 27.98 - 28.28
52wk Range 25.20 - 40.37
Shares Outstanding 5,606,688,356
Dividend Yield 5.84%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 Beaten-Down Stocks to Buy and Hold for 10 Years
They offer plenty of upside and solid dividend growth. 
Via The Motley Fool
FDA Delays 'Important' Moderna Vaccine Review: William Blair Says 2025 Growth, '2026 Breakeven Story' Depends On It
FDA update: Moderna's BLA for mRNA-1345, RSV vaccine, may face delay past May 12 deadline. But no safety concerns reported. 
Via Benzinga
Exposures Product Safety

Performance

YTD
-5.57%
-5.57%
1 Month
+4.84%
+4.84%
3 Month
+1.83%
+1.83%
6 Month
-5.41%
-5.41%
1 Year
-26.70%
-26.70%

More News

Read More
Moderna Dives Back Into Buy Zone After FDA Delays Its RSV Vaccine
Via Investor's Business Daily
Exposures Product Safety
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields
Via Benzinga
7 F-Rated Stock Picks to Avoid Like the Plague in May
Via InvestorPlace
Topics Electric Vehicles
Exposures Electric Vehicles
Spotlight on Pfizer: Analyzing the Surge in Options Activity
Via Benzinga
Pfizer's Options Frenzy: What You Need to Know
Via Benzinga
3 Biotech Stocks to Sell in May Before They Crash & Burn
Via InvestorPlace
The 3 Most Undervalued Healthcare Stocks to Buy in May 2024
Via InvestorPlace
Safeguard Your Future: Top 3 Stocks to Weather Any Market Downturn
Via InvestorPlace
3 Profitable Dividend Stocks to Buy at Near-Lows
Via InvestorPlace
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
Via InvestorPlace
2 No-Brainer Dividend Stocks to Buy in May
Via The Motley Fool
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Via Benzinga
This 6% Yielding Dividend Stock Could Pump Up Your Passive-Income Stream
Via The Motley Fool
Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Second Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle Wasting Disorder Trial
Via Benzinga
Just Say No to Drugs: 3 Pharma Stocks to Avoid
Via InvestorPlace
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
Via FinancialNewsMedia
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
Via The Motley Fool
Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
From FN Media Group LLC
Via GlobeNewswire
Jim Cramer Advises Investors To Brace For Economic Slowdown, Shares Tips To Maintain Balanced Portfolio: 'I'm Not Telling You To Relax'
Via Benzinga
Topics Economy
Exposures Economy
A Look At Pharma ETFs Post Q1 Earnings
Via Talk Markets
Topics ETFs
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
Via InvestorPlace
Tuesday Talk: Still Flying
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.